Lymphoplasmacytic Lymphoma Recruiting Phase 2 Trials for Allopurinol (DB00437)

Indication	Status	Phase
DBCOND0031072 (Lymphoplasmacytic Lymphoma)	Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT02661035	Allo HSCT Using RIC for Hematological Diseases	Treatment	Allopurinol (DB00437) Cyclophosphamide (DB00531) Fludarabine (DB01073) Mycophenolate mofetil (DB00688) Tacrolimus (DB00864)